AVEO: Q2 Earnings Snapshot
BOSTON (AP) _ AVEO Pharmaceuticals Inc. (AVEO) on Thursday reported a loss of $8.3 million in its second quarter.
On a per-share basis, the Boston-based company said it had a loss of 24 cents.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The cancer drug company posted revenue of $25.3 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $26 million.
AVEO shares have risen 65% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $7.74, an increase of 48% in the last 12 months.